Quick Recall

Which of the following statement is FALSE regarding Tocilizumab?

367 Votes

4 Likes

LikeAnswersShare

ANSWER is D - as it is a false statement- because- favourable outcomes have been reported in COVID-19 patients who required mechanical ventilation All other answers are correct A - is correct as it anti - interleukin - 6 and hence calms the cytokine storm B - It is prescribed in moderate to severe cases of Rheumatoid arthritis C -As it is an immuno- suppressant- it may increase the likelihood of secondary infections

C is false .My increase the likelihood of secondary / super infections ..This is false regarding Tocilizumab . Such type of complications not reported till date

POSSIBLY ...*D*.... AS. IT. IS. STILL. USED. IN. ARDS. ASSOCIATED. WITH. COVI 19. INFECTION..... REQUIRING . ...*MECHANICAL. VENTILATION.* .. . DESPITE. HIGH. RATE. OF. OCCURRENCES. OF SUPERINFECTION. .. SINCE .. IT. IS. ASSOCIATED. WITH. IMPROVED. OUTCOME

I don't think there is any increase in secondary infection when pt is on Tocilizumab in covid care

Thanx dr Vedprakash Singh
0

View 1 other reply

Right now option C is not suitable for this debate/voting and is controversial because as yet this newly drug discovered by DRDO has been not frequently prescribed like Corticosteroids and hece its side effects little known. Wait for few months more to know the secondary infections likelihood.

D

Thanks doctor
0

E : as it is an immunosuppressive drug, hence may increase the secondary bacterial or fungal infections & may cause mortality in few covid pts.

E ) is right

Toclizumab reduces the activity of IL6 thereby reducing the Inflammation ,Cytokine storm So the Answer is supposed to be C

Its c

Load more answers

Diseases Related to Discussion